Therapie des kastrationsrefraktären Prostatakarzinoms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapie des kastrationsrefraktären Prostatakarzinoms

Published:2012-07-20 Issue:15-16 Volume:124 Page:538-551
ISSN:0043-5325
Container-title:Wiener klinische Wochenschrift
language:de
Short-container-title:Wien Klin Wochenschr

Author:

Rauchenwald Michael,Krainer Michael,Bauernhofer Thomas,De Santis Maria,Höltl Wolfgang,Kramer Gero,Krause Steffen,Loidl Wolfgang,Oismüller Renée,Reissigl Andreas,Schmeller Nikolaus,Stackl Walter,Stoiber Franz,Füreder Thorsten

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00508-012-0206-1.pdf

Reference118 articles.

1. National Cancer Institute. Stage distribution and 5-year relative survival by stage at diagnosis for 2001–2007. SEER – Surveillance Epidemiology and End Results. 2011.

2. Vutuc C, Waldhoer T, Madersbacher S, et al. Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality. Eur J Cancer Prev. 2001;10(5):425–8.

3. Statistik Austria. Krebsinzidenz und Krebsmortalität in Österreich. Wien: Statistik Austria; 2010. Cited nh002978. http://www.statistik.at/web_de/static/krebsinzidenz_und_krebsmortalitaet_in_oesterreich_2010_045664.pdf .

4. Chen CD, Welsbie DS, Tran C, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med. 2004;10(1):33–9.

5. Chen Y, Sawyers CL, Scher HI. Targeting the androgen receptor pathway in prostate cancer. Curr Opin Pharmacol. 2008;8(4):440–8.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP